| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.004 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |